Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketty Peris

Showing results (381-390 of 533) with videos related to

Pageof 54
Sort By:
Critical Reviews in Oncology/Hematology|July 13, 2023
Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitorsPaolo Bossi, Paolo A Ascierto, Nicole Basset-Seguin, et al.
Dermatologic Therapy|April 6, 2022
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life studyGiacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini, et al.
Dermatologic Therapy|August 1, 2021
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort studyAnna Campanati, Laura Atzori, Concetta Potenza, et al.
BMC Cancer|November 13, 2024
Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinomaRalf Gutzmer, Ulrike Leiter, Peter Mohr, et al.
Diagnostics (Basel, Switzerland)|December 9, 2023
Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin LesionsAlessandro Di Stefani, Simone Cappilli, Giovanni Cuffaro, et al.
Journal of the American Academy of Dermatology|July 21, 2022
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trialAndrew Blauvelt, Richard G Langley, Jean-Philippe Lacour, et al.
Scientific Reports|June 25, 2021
Molecular alterations in basal cell carcinoma subtypesLucia Di Nardo, Cristina Pellegrini, Alessandro Di Stefani, et al.
The Journal of Investigative Dermatology|April 15, 2006
The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populationsTania Spica, Marc Portela, Bénédicte Gérard, et al.
Frontiers in Oncology|February 27, 2023
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative studyPaolo A Ascierto, Eleonora Cioli, Vanna Chiarion-Sileni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2024
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi studyAnouk G M Caron, Astrid M van Huizen, Annelie A H Musters, et al.
Pageof 54

Showing results (381-390 of 533) with videos related to

Sort By:
Pageof 54
Critical Reviews in Oncology/Hematology|July 13, 2023
Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitorsPaolo Bossi, Paolo A Ascierto, Nicole Basset-Seguin, et al.
Dermatologic Therapy|April 6, 2022
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life studyGiacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini, et al.
Dermatologic Therapy|August 1, 2021
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort studyAnna Campanati, Laura Atzori, Concetta Potenza, et al.
BMC Cancer|November 13, 2024
Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinomaRalf Gutzmer, Ulrike Leiter, Peter Mohr, et al.
Diagnostics (Basel, Switzerland)|December 9, 2023
Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin LesionsAlessandro Di Stefani, Simone Cappilli, Giovanni Cuffaro, et al.
Journal of the American Academy of Dermatology|July 21, 2022
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trialAndrew Blauvelt, Richard G Langley, Jean-Philippe Lacour, et al.
Scientific Reports|June 25, 2021
Molecular alterations in basal cell carcinoma subtypesLucia Di Nardo, Cristina Pellegrini, Alessandro Di Stefani, et al.
The Journal of Investigative Dermatology|April 15, 2006
The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populationsTania Spica, Marc Portela, Bénédicte Gérard, et al.
Frontiers in Oncology|February 27, 2023
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative studyPaolo A Ascierto, Eleonora Cioli, Vanna Chiarion-Sileni, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2024
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi studyAnouk G M Caron, Astrid M van Huizen, Annelie A H Musters, et al.
Pageof 54